Riskpilot← Back to searchSign inGet full accessGambei AB
ABActiveOrg 5567165559Fammarp 370Medical specialists activities · NACE 8622Est. 20062 employees
Revenue 2025
SEK 5,5M
-6% vs 2024
EBITDA margin
26.9%
+61% vs 2024
Equity ratio
39.0%
Financial strength
Net profit 2025
SEK 884K
+194% vs 2024
| Revenue | SEK 5,5M | -6% |
| EBITDA | SEK 1,5M | +61% |
| Net profit | SEK 884K | +194% |
| Total assets | SEK 3,5M | +33% |
| Equity | SEK 1,3M | +190% |
| Employees | 2 | — |
Legal name
Gambei AB
Org number
5567165559
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 november 2006
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva hälso- och sjukvårdsverksamhet, ekonomisk konsultations- och rådgivningsverksamhet, idka köp- och försäljning av värdepapper, köp och försäljning samt uthyrning av fast egendom och bostadsrätter samt bedriva uthyrning av desamma samt därmed förenliga verksamheter.
Address
Fammarp 370
Phone
+46707346319
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 4 033 | 5 427 | 5 877 | 5 817 | 5 492 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 867 | 1 710 | 3 132 | 916 | 1 477 |
| Depreciation & amort. | −94 | −44 | −122 | −200 | −44 |
| EBIT | 773 | 1 666 | 3 010 | 716 | 1 433 |
| Net financials | 99 | — | −5 605 | — | — |
| Profit before tax | 537 | 1 405 | −2 212 | 463 | 1 159 |
| Tax | −112 | −316 | −408 | −162 | −275 |
| Net profit | 425 | 1 089 | −2 620 | 301 | 884 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 209 | 6 254 | 2 571 | 2 604 | 3 455 |
| Equity | 1 996 | 3 084 | 164 | 465 | 1 349 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 677 | 1 304 | 1 349 | 872 | 682 |
| Total debt | 1 677 | 1 304 | 1 349 | 872 | 682 |
EBITDA margin
26.9%
This company
15.8%
Market median
+70% vs market
20212025
Equity ratio
39.0%
This company
38.2%
Market median
+2% vs market
20212025
Return on equity
65.5%
This company
18.4%
Market median
+256% vs market
20212025
Net profit margin
16.1%
This company
8.1%
Market median
+99% vs market
20212025
Asset turnover
1.59×
This company
1.12×
Market median
+42% vs market
20212025
Debt / equity
1.56×
This company
0.62×
Market median
-152% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CM | Audit | 2022 |
| Former (1) | ||
SR | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2026 | |
| Deputy Board Member | 2026 | |
| Board of Directors | 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gambei AB 
Fammarp 1:2 ABBoard members of Gambei AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Staffan Roland Persson | Audit | 0 companies |
| Claes Magnus Jonasson | Audit | 0 companies |
| Bo Michael Wirén | Chairman | 0 companies |
| Ulla-Mi Lagesdotter Nyhuus Wirén | Deputy Board Member | 0 companies |
| Klara Li Fredrika Michaela Wirén | Board of Directors | 0 companies |